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Abstract: Hypothermia may attenuate the progression of ischemia-induced damage in liver.
Here, we determined the effects of a brief cycle of hypothermic preconditioning applied before
an ischemic/reperfusion (I/R) episode in isolated perfused rat liver (IPRL) on tissue damage
and oxidative stress. Rats (male, 200–250 g) were anaesthetised with sodium pentobarbital
(60 mg·kg−1 i.p) and underwent laparatomy. The liver was removed and perfused in a
temperature-regulated non-recirculating system. Livers were randomly divided into two groups
(n = 6 each group). In the hypothermia-preconditioned group, livers were perfused with hypothermic
buffer (cycle of 10 min at 22 ◦C plus 10 min at 37 ◦C) and the other group was perfused at 37 ◦C.
Both groups were then submitted to 40 min of warm ischemia and 20 min of warm reperfusion.
The level of tissue-damage indicators (alanine amino transferase, ALT; lactate dehydrogenase,
LDH; and proteins), oxidative stress markers (thiobarbituric acid-reactive substances, TBARS;
advanced oxidation protein products, AOPP; and glutathione, GSH) were measured in aliquots
of perfusate sampled at different time intervals. Histological determinations and oxidative stress
biomarkers in homogenized liver (AOPP; TBARS; nitric oxide derivatives, NOx; GSH and glutathione
disulphide, GSSG) were also made in the tissue at the end. Results showed that both damage and
oxidant indicators significantly decreased while antioxidant increased in hypothermic preconditioned
livers. In addition, homogenized liver determinations and histological observations at the end of
the protocol corroborate the results in the perfusate, confirming the utility of the perfusate as a
non-invasive method. In conclusion, hypothermic preconditioning attenuates oxidative damage and
appears to be a promising strategy to protect the liver against IR injury.
Keywords: glutathione; hypothermic preconditioning; ischemia/reperfusion injury;
lipid peroxidation
1. Introduction
During liver surgery and transplantation, a serious clinical problem arises: the transient ischemia
and reperfusion injury (IRI) [1–3]. IRI is a complex damage attributable to various factors. First,
when the donor liver undergoes the process of retrieval surgery followed by cooling storage,
energy consumption is reduced. Effects associated with anaerobic metabolism included lactate
acidosis [4], proteolysis [5] and sinusoidal endothelial damage [3] among others. During implantation,
grafts are exposed to reperfusion, normothermia and oxygenation, a process that triggers the release of
reactive oxygen species (ROS) and inflammatory mediators [3,6].
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Due to the wide diversity of mechanisms involved in IRI, many therapeutic mechanisms have
been suggested to prevent hepatic damage [7]. Pharmacological interventions [2,8–10] and the different
preconditioning mechanisms are the most common strategies [11–13].
Recently, hypothermic oxygenated perfusion has been proven to be successful in protecting livers
from reperfusion injury [14–16], in a mechanism due to a change in the mitochondrial redox state and
subsequent decrease in ROS generation [15]. A therapeutic role for hypothermia has been demonstrated
in many tissues and against diverse injuries [17] and protective effects were first suggested to be a
consequence of cellular metabolism reduction, thus preserving ATP levels [18]. Reduction of oxidative
stress as well as in antioxidant consumption has also been shown [19,20]. Hypothermic perfusion
was also proven to work as a preconditioning agent in isolated hearts [21]: When hypothermic
perfusion was applied prior to ischemia and reperfusion, improvement in the metabolic state of the
tissue and decrease in oxidative stress damage was found [21]. The use of hypothermic perfusion
(20 ◦C) in isolated livers resulted in protecting cellular integrity [22]. Moreover, our previous work
demonstrated that hypothermic perfusion (22 ◦C) stimulated several mechanisms of cell protection,
including antioxidants and the activation of lysosomal and proteasomal systems to repair oxidative
damage [23]. These effects of hypothermic perfusion lead us to consider whether hypothermia could
be used as a preconditioning model in isolated perfused rat liver (IPRL).
In the present study, we determined the effects of a short hypothermic perfusion (10 min at 22 ◦C)
in isolated liver when applied before an ischemic/reperfusion episode by means of tissue damage
indicators and oxidative stress parameters released in perfusate.
The main novelty of our work is the fact that hypothermia can be used as a preconditioning
method. In addition, we have also shown that liver status can be monitored with non-invasive
techniques, using aliquots of the effluent perfusate.
2. Results
We evaluated some parameters of tissue damage and oxidative stress in the perfusate collected in
an isolated perfused rat liver (IPRL) model at different times during preconditioning, ischemia and
reperfusion. The IPR livers were randomly treated with hypothermic perfusion (22 ◦C) for 10 min
(hypothermia, PC IR group) or perfused at 37 ◦C (normothermia, IR group). Both groups were then
submitted to 10 min at 37 ◦C followed by 40 min of ischemia and 20 min of reperfusion at 37 ◦C.
Perfusate was sampled at different time intervals: after preconditioning (10 min), before ischemia
(20 min), during reperfusion (70 min) and at the end of reperfusion (80 min). At the end, liver tissue
and homogenates were also analysed and compared to fresh resected livers (see Figure 1).
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Figure 1. Schematic representation of experimental design. The IPR livers were randomly
treated with hypothermic perfusion (22 ◦C) during 10 min (PC IR group) or perfused at 37 ◦C
(IR group). Both groups were then submitted to 10 min at 37 ◦C. The perfusion was conducted
under temperature-controlled conditions. The liver, kept moist in KHB solution, was placed in a
temperature-controlled box, surrounded by a continuously stirred buffer at the set temperature (37 ◦C or
22 ◦C). Control of liver temperature was carried out with a thermocouple located at the catheter in the
thoracic inferior vena cava. After the preconditioning period (20 min), ischemia (40 min) was induced
by stopping the perfusion machine while keeping the liver-containing device surrounded by warm
water to avoid cooling. Reperfusion was initiated by turning on the perfusion machine, circulating with
warm buffer at 37 ◦C. Perfusate was sampled at different time intervals: after preconditioning (10 min),
before ischemia (20 min), after ischemia/reperfusion (70 min) and at the end of reperfusion (80 min).
At the end, liver extracts were also analysed to be compared to fresh resected livers.
2.1. Effect of Hypothermic Perfusion on Cellular Integrity
As an index of cellular injury, alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and
the concentration of proteins in the perfusate were measured. ALT is mainly present in the cytoplasm
of hepatocytes and its release increases with minor liver damage. LDH is a non-liver specific enzyme
present in hepatocytes and non-parenchymal cells, used as a biomarker of general tissue-damage.
Our results showed a significant increase of ALT and LDH after 20 min of perfusion (Figure 2A,B).
The increase in released proteins was more significant, since it was observed earlier: at 70 min and
80 min of the experiment, during reperfusion (Figure 3). Thus, hypothermic preconditioning better
preserves cellular integrity.
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Figure 2. Effect of hypothermic perfusion on cellular integrity. (A) Alanine aminotransferase (ALT)
in the perfusate; and (B) lactate dehydrogenase (LDH) in the perfusate. Data is mean ± SEM of six
animals. Significantly different from corresponding PC IR values by Student’s t test: ** p < 0.01.
Figure 3. Effect of hypothermic perfusion on cellular integrity. Total protein content in the perfusate.
Data is mean ± SEM of six animals. Significantly different from corresponding PC IR values by
Student’s t test: *** p < 0.001.
2.2. Effect of Hypothermic Perfusion on Biomarkers of Oxidative Stress in the Perfusate
As effects of oxidative stress, lipid peroxidation and protein oxidation were both measured.
Lipid peroxidation was determined as the end product malondialdehyde by the thiobarbituric reactive
substances (TBARS). In Figure 4A, we can see a significant increase in TBARS due to reperfusion in the
IR group. We also measured the levels of advanced oxidation protein products (AOPP). AOPP has
been identified as a biomarker of oxidative damage to proteins, detecting dityrosine and cross-linking
protein products [24]. In Figure 4B, we can observe a dramatic increase in AOPP production due to the
reperfusion in the IR group at both 70 and 80 min.
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Figure 4. Effect of hypothermic perfusion on biomarkers of oxidative stress in the perfusate. (A) Lipid
peroxidation (TBARS) (B) Advanced oxidation protein products (AOPP) and (C) GSH levels in the
perfusate. Data is mean ± SEM of six animals. Significantly different from corresponding PC IR values
by Student’s t test: * p < 0.05, ** p < 0.01 and *** p < 0.001.
Under physiological conditions, oxidative stress can be avoided by the action of antioxidants.
Glutathione (GSH) is one of the most ubiquitous antioxidant molecules [25,26] and, therefore, the levels
of GSH in the perfusate were measured (Figure 4C). Reduced levels of GSH were found in the IR group
at 20, 70 and 80 min of the experiment, indicating that the GSH decrease starts before ischemia and it
remains stable in the reperfusion process.
2.3. Effect of Hypothermic Preconditioning on Oxidant/Antioxidant Parameters in Liver after Ex Vivo Warm
Ischemia and Reperfusion Perfusion
At the end of the ischemia/reperfusion protocol (80 min), livers were removed, and parameters
were compared to fresh resected livers (Baseline); 5 µm sections of liver tissues fixed in formalin were
stained with hematoxylin and eosin. Figure 5 shows the histology of the Baseline liver (fresh resected),
PC IR and IR liver. In the images, we can see that the liver tissue in IR group has changed with large
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sinusoidal spaces between groups of cells, suggesting the loss of the extracellular matrix. In contrast,
the tissue of the PC IR sample is better preserved.
Figure 5. Histology hematoxylin-eosin staining. Photomicrographs at 10× magnification. Baseline:
Fresh resected livers; PC IR: livers were preconditioned with hypothermic perfusion (22 ◦C) for
10 min and 10 min of normothermia previous to 40 min of ischemia and 20 min of reperfusion.
IR: livers were perfused at normothermia, 37 ◦C for 20 min and then submitted to 40 min of ischemia and
20 min of reperfusion. Liver sections were stained with hematoxylin and eosin according to standard
procedures. Scale bar, 250 µm. Tissue injury was scored as described in the Material and Methods
section. Significantly different from corresponding Baseline values: +++ p < 0.001. Significantly different
from corresponding PC IR values: *** p < 0.001.
Liver extracts were also homogenized, biochemical assays were performed and compared to fresh
resected livers. Results in Table 1 showed that oxidant indicators measured as protein oxidation
(AOPP), lipid peroxidation (TBARS) and nitric oxide (NOx) significantly increased in IR livers,
when compared to fresh resected livers or to hypothermic preconditioned (PC IR) livers. It has been
pointed out that nitric oxide, measured as nitrate plus nitrite, has a dual role: as a vasodilator regulates
the hepatic microvascular perfusion, but it also acts as a pro-oxidant free radical. Total glutathione
(that includes both forms, reduced and oxidized (GSH + GSSG), and the reduced form (GSH) decreased
in IR livers, confirming glutathione depletion due to I/RI, that was avoided in the preconditioned livers.
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Table 1. Effect of hypothermic preconditioning on oxidant/antioxidant parameters in liver after ex
vivo warm ischemia reperfusion.
Fresh Resected Baseline Hypothermia PC IR Normothermia IR
AOPP µmol/g wet weight 6.86 ± 0.19 4.33 ± 0.76 + 6.36 ± 0.49 *
TBARS nmol/g wet weight 37.35 ± 1.32 37.22 ± 5.15 61.40 ± 9.45 *+
NOx µmol/g wet weight 0.16 ± 0.02 0.23 ± 0.06 0.43 ± 0.07 *++
GSH + GSSG µmol/g wet weight 1.66 ± 0.10 1.22 ± 0.25 0.79 ± 0.12 +
GSH µmol/g wet weight 1.32 ± 0.07 1.11 ± 0.22 0.50 ± 0.07 **++
Livers were treated as followed: Fresh resected livers (Baseline); in hypothermia PC IR group, livers were
preconditioned with hypothermic perfusion (22 ◦C) for 10 min and 10 min of normothermia (37 ◦C) previous
to 40 min of ischemia and 20 min of reperfusion. IR livers were perfused at normothermia for 20 min and
then submitted to 40 min of ischemia and 20 min of reperfusion. Oxidant indicators were the concentration of
advanced oxidation protein products (AOPP), thiobarbituric acid-reactive substances (TBARS) and nitric oxide
derivatives (NOx). Antioxidant status was evaluated as total (GSH + GSSG) and reduced glutathione (GSH). Data is
mean ± SEM of six animals. Significantly different from corresponding Baseline values: + p < 0.05 and ++ p < 0.01.
Significantly different from corresponding PC IR values: * p < 0.05 and ** p < 0.01.
3. Discussion
Hypothermia is defined as the situation in which the temperature of an organism is below
its normal range (inferior to 37 ◦C). There are currently many studies on the therapeutic use of
hypothermia in certain diseases. It is particularly recommended as a treatment in pathological or
surgical situations [17,27]. In this context, hypothermia has improved the outcomes of patients with
ischemic and traumatic brain accidents [28–30], as well as those who have had acute myocardial
infarction [31,32] among others. Benefits of hypothermia may be related to a reduction in metabolism,
affecting the catalytic enzymatic reactions and the oxygen consumed, thus maintaining ATP levels [18].
This is particularly important during an episode of ischemia and reperfusion since ischemia tends to
the ATP exhaustion and reperfusion tends to the increase in the acid charge [33].
One of the feasible applications of hypothermia has to do with its role as a protective mechanism
against the damage caused by ischemia/reperfusion (IR). Within the IR process, we can find an injury
based on two fundamental components: (1) the lesion produced during the period of ischemia due
to the lack of oxygen; and (2) the injury produced during the reperfusion process, mainly due to
the synthesis of various inflammatory mediators and the generation of reactive oxygen and nitrogen
species (RONS) after the restoration of the blood flow. Our previous work demonstrated that a
brief hypothermic perfusion (22 ◦C) in isolated perfused rat liver (IPRL) induced cellular protection,
related to antioxidant and proteasomal function [23].
These beneficial effects led us to explore the potential use of hypothermia as a preconditioning
model for ischemia/reperfusion injury.
Our model of a short hypothermic perfusion (10 min at 22 ◦C) could fit well with the use of redox
signalling as a physiological tool by the cell. In our previous assay, perfusion of livers with a cold buffer
during 15 min resulted in a slight increase of both lipid peroxidation and protein oxidation in livers,
evidencing a minor oxidative stress. At the same time, detoxifying systems such as glutathione or
proteasomal systems appeared to be enhanced in livers [23]. Those adaptive intracellular mechanisms
would be involved in the increased resistance of the hypothermia-preconditioned livers against
IR challenge. For a cell, any adaptation strategy against a challenge will result either in death or
survival, and mostly it is a matter of time. The results of this experiment are in accordance with this
hypothesis. The use of a brief hypothermia perfusion as a “preconditioning” factor clearly triggered
protective mechanisms in the cells that prepare the tissue for dealing with the ischemia and reperfusion
process, therefore mitigating liver damage, decreasing tissue damage indicators (i.e., release of ALT,
LDH and proteins into the perfusate), and cellular integrity preservation according to tissue histology.
By looking at the levels of ALT and LDH in perfusate, it can be observed how there is a reduction in
both enzymatic activities. The concentration of the enzymes in the cells is determined by the rate of
their synthesis and degradation. In a previous work, we have shown that hypothermia causes the
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stimulation of the activity of cell proteolysis through the improvement of the proteasome system of
ubiquitin and the lysosomal proteolytic machinery [23]. Therefore, we cannot exclude that an increase
in the proteasomal degradation rate of many proteins in preconditioned livers with hypothermia
would result in a lower enzyme activity of ALT and LDH. However, recently it has been reported
that hypothermia-ischemia affects reaction velocity (Vm) and also Michaelis constant (Km) in the
enzymatic activity of LDH [34]. According to these significant data, hypothermia induces structural
modifications of the LDH molecules, and not a decrease in their number. It has been suggested that
the decrease in LDH activity maintains the level of low glycolytic lactate in tissues under ischemic
conditions and hence contributes to the cellular protection of hypothermia [34].
As is well-accepted, oxidative burst induced by reperfusion impacts on biomolecules such as
lipids and proteins. Moreover, ischemia and reperfusion decreased both total and reduced glutathione,
the most important antioxidant molecule [35], in tissue. Because the increased recovery of GSH in
the perfusate can indicate the toxicity resulting from the loss of cellular glutathione, the cellular
contents in glutathione were analysed. As presented in Table 1, intracellular glutathione levels argue
against depletion caused by greater elimination in pre-treated liver hypothermia, indicating protection
against IR-induced depletion and suggesting that the increase in GSH levels in the perfusate could
have another origin. In this sense, the lower degree of oxidative stress induced by short exposure to
hypothermia (Table 1, Figure 4C) could promote a more GSH/GSSG balance in favour of GSH in the
perfusate. Glutathione depletion impairs detoxification, increasing the formation of the advanced
products of lipid peroxidation [36], coinciding with increasing release of AOPP and TBARS into the
perfusate of IR group. In contrast, oxidative parameters decreased and antioxidants increased in the
hypothermia PC IR group. Our results suggest that the protection due to hypothermia would be
related to the preservation of the main antioxidant molecule glutathione [23,37].
Overall, this confirms our hypothesis that hypothermic preconditioning can be useful in avoiding
oxidative damage; or in other words, the high levels of lipid peroxidation found in the liver during the
ischemia reperfusion injury can be reversed thanks to the preconditioning methodology [38,39].
Moreover, the designed protocol allowed us to evaluate liver parameters in the eluted perfusate
while contrasting them with the results in liver extracts after the IR protocol. We have found that the
indices in the perfusate were corroborated by the tissue values. Therefore, our results can be applied in
clinical terms, since perfusion values are faster to obtain and much less invasive than those that could
be obtained from a tissue biopsy, so that it could be easily transferred to clinical transplants.
4. Materials and Methods
4.1. Animals and Liver Isolation and Perfusion
Adult male Sprague–Dawley rats (225–250 g body weight) were used in the study of isolated
perfused rat liver (IPRL). Rats were fasted overnight and had free access to water. Rats were
anesthetized with i.p. sodium pentobarbital (60 mg/Kg). Heart failure was induced by incision
in the diaphragm and the liver was isolated and connected for perfusion in a non-recirculating system
at a flow rate of 3 mL/min/g liver with Krebs-Henseleit buffer (KHB) (mM): 118 NaCl, 4.7 KCl,
1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2, 25 NaHCO3, 20 Hepes (pH 7.4), aerated with 95% O2 and 5% CO2
The IPRL model was used as described by Vairetti [33] and others [40,41] with later modifications by
our group [23]. The procedure was approved on the 8 February 2012 by the University of Barcelona
Institutional Committee of Animal Care and Research (permission code DMAH 4125) and followed
European Community guidelines.
Livers were randomly divided in 2 groups (n = 6). In the preconditioned group, livers were
treated with hypothermic perfusion (22 ◦C) during 10 min (hypothermia preconditioning, PC IR group),
and compared with livers perfused at 37 ◦C (Normothermia, IR group). The perfusion was conducted
under temperature-controlled conditions. The liver, kept moist in KHB’s solution, was placed in a
temperature-controlled box, surrounded by continuously stirred buffer at the set temperature (37 ◦C
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or 22 ◦C). Control of liver temperature was carried out with a thermocouple located at the catheter
in the thoracic inferior vena cava. Both groups were then submitted to 10 min at 37 ◦C followed
by 40 min of ischemia and 20 min of reperfusion at 37 ◦C. Ischemia was induced by stopping the
perfusion machine while keeping the liver-containing device surrounded by warm water to avoid
cooling. Reperfusion was initiated by turning on the perfusion machine, circulating with warm buffer.
Aliquots of 20 mL of perfusate were sampled at different times: 10 min (after hypothermia or
normothermia perfusion); 20 min (before ischaemia); at 70 min (ischaemia plus 10 min of reperfusion);
and at 80 min (ischaemia plus 20 min of reperfusion). All samples were immediately centrifuged at
800× g for 5 min at 4 ◦C to remove any cells. Fresh perfusate was used for lactate dehydrogenase (LDH)
determinations and the remaining supernatant was frozen at −20 ◦C for lyophilisation. Samples of
perfusate were lyophilized to dryness and diluted on the day of the assay according to the conditions
of each test.
Freshly resected livers (Baseline) and livers from PC IR and IR groups were collected. From each
liver some samples were kept fixed in formalin, and some samples were frozen in liquid nitrogen and
stored at −80 ◦C until analysis for biochemical determinations.
4.2. Biochemical Assays in the Perfusate
As an index of tissue injury, alanine amino transferase (ALT) and lactate dehydrogenase (LDH)
were measured using commercial kits (BioSystems, Barcelona, Spain) and expressed as U/L.
The total protein content in perfusate (µg/mL) was determined using the Bradford
protein assay [42], and the formation of advanced oxidation protein products (AOPP) was
spectrophotometrically measured at 340 nm following Witko–Sarsat’s method [24]. Results were
obtained through a standard calibration curve using 100 µL of chloramine-T solution (0–100 µmol/L).
AOPP levels were expressed as nmol·g−1·min−1 of Chloramine-T equivalents.
As a product of lipid peroxidation, we measured thiobarbituric acid reactive substances (TBARS),
in accordance with the method of Yagi [43]. The chain-breaking antioxidant, butylated hydroxytoluene,
and the iron chelator, EDTA, were used to prevent amplification of peroxidation during the assay.
Results were expressed as TBARS in picomol·g−1·min−1 and compared to a standard obtained by the
acid hydrolysis of tetraethoxypropane.
Glutathione groups in diluted lyophilized perfusate were measured using Ellman’s reagent in
accordance with Hu [44] and were expressed as nmol·g−1·min−1.
4.3. Oxidant and Antioxidant Assays in Liver
Livers from PC IR and IR groups, and freshly resected livers (Baseline) were homogenized in
10% (w/v) with a teflon bar in a RIPA solution, (Tris 1 M, pH 7.5, Triton 10×, NaCl 5 M, NaF 1 M)
containing antiprotease solution (aprotinin at 1.7 mg/mL, 2 µg/mL pepstatin, 2 µg/mL leupeptin
and 1 mM phenylmethylsulfonyl fluoride and sodium ortovanadate at 1 mM). The suspension was
centrifuged at 2000× g for 5 min and the cytosolic fraction discarded.
Advanced oxidation protein products (AOPP) in liver homogenates were assayed by a
modification of Witko–Sarsat’s method [24,45]. The formation of AOPP was measured at 340 nm using
100 µL of Chloramine-T solution (0–100 µmol/L) as a standard calibration curve. AOPP was expressed
as µmol/g wet weight.
Lipid peroxidation in livers was determined as the end-product malondialdehyde (MDA) by
thiobarbituric reactive substances (TBARS) assay [46]. The formation of MDA-TBA adduct was
fluorometrically measured at an excitation wavelength of 515 nm and an emission wavelength of
550 nm. The calibration curve was determined using tetraethoxypropane. Values are expressed in
nmol/g wet weight.
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Nitric oxide levels were measured as nitrate plus nitrite (NOx) in liver homogenates ultrafiltered by
means of a 30 kDa molecular weight cut-off filter, using a colorimetric assay kit (Cayman Chemical Co.,
Ann Arbor, MI, USA). In the assay, nitrate was converted to nitrite using nitrate reductase and total
nitrite was measured using the Griess reaction and expressed as µmol/g wet weight.
For measuring reduced glutathione (GSH) and oxidized glutathione (GSSG), liver was
homogenized in a cold buffer containing 5 mm phosphate-EDTA buffer (pH 8.0) and 25% HPO3.
The homogenates were ultra-centrifuged at 100,000× g and 4 ◦C for 30 min, and the resulting
supernatant was used to determine GSH and GSSG concentrations, using the fluorescent probe
o-phthalaldehyde. Fluorescence was determined at a wavelength emission of 420 nm and excitation at
350 nm [23,37]. Results are expressed as µmol/g wet weight.
4.4. Histology
Liver tissues were fixed in 10% neutral buffered formalin and embedded in Paraplast
(Sigma Aldrich, Madrid, Spain), and 5 µm sections were stained with hematoxylin and eosin according
to standard procedures. Samples were assessed according to the scoring system for nonalcoholic fatty
liver disease proposed by Kleiner [47], with a minor modification: that is, considering the sum of
steatosis (0–3), lobular inflammation (0–3), hepatocellular ballooning (0–2), together with dilatation of
sinusoids (0–3).
4.5. Statistics
Results are expressed as means ± SEM of six animals. Data were processed using the statistical
software GraphPad InStat (GraphPad Software, Inc., San Diego, CA, USA). The means of the
experimental groups in perfusate samples were analyzed by the Student’s t test to identify significant
differences between the two groups PC IR and IR at the same time intervals. Data of the liver
biochemical and histological assays were analyzed by two-way ANOVA (when p < 0.05) using the
post-hoc Student–Newman–Keuls test to identify significant differences between the Baseline, PC IR
and IR groups.
5. Conclusions
In conclusion, hypothermic preconditioning at 22 ◦C in the liver is able to maintain the glutathione
content and to attenuate the hepatic oxidative damage induced by ischemia/reperfusion and appears
to be a promising strategy to precondition the liver against ischemic damage.
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